MSI PIs Receive Grants From Minnesota Partnership


MSI PIs are among the researchers who have received grants from the Minnesota Partnership for Biotechnology and Medical Genomics. PIs head three of the five projects that received research grants for 2021.

  • Michael Barry (Mayo Clinic); David Masopust (professor, Microbiology and Immunology)
    • Project: Developing vaccination regimens that generate multifunctional, long-lived, and re-activatable B and T cell immunity for SARS-CoV-2
  • Scott Kaufmann (Mayo Clinic); Daniel Harki (associate professor, Medicinal Chemistry)
    • Project: Tools to assess DNMT-DNA covalent complex formation
  • Carol Lange (professor, Medicine); Antonio D’Assoro (Mayo Clinic)
    • Project: Dual targeting of aurora-A and progesterone receptor (PR) driven signaling pathways to enhance the therapeutic efficacy of DCK4/6 inhibitors in endocrine resistant breast cancer

The complete list of awardees and descriptions of the projects can be found on the University of Minnesota news site: Minnesota Partnership Awards 5 Colaborative Research Grants for 2021.

The Minnesota Partnership, established in 2003, is dedicated to using the combined knowledge, resources and expertise of the University of Minnesota and Mayo Clinic to advance health care and scientific discoveries, especially for the people of Minnesota.